Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-107
Closed -$13.7K 381
2024
Q2
$13.7K Sell
107
-25,272
-100% -$1.06M ﹤0.01% 444
2024
Q1
$1.09M Sell
25,379
-734
-3% -$30.3K 0.16% 127
2023
Q4
$968K Sell
26,113
-121
-0.5% -$4.34K 0.16% 126
2023
Q3
$951K Sell
26,234
-11
-0% -$390 0.17% 121
2023
Q2
$935K Buy
26,245
+145
+0.6% +$5.2K 0.17% 124
2023
Q1
$929K Buy
26,100
+2,664
+11% +$93.2K 0.17% 119
2022
Q4
$831K Buy
+23,436
New +$781K 0.21% 81

Other funds holding GSK

Great Lakes Retirement's GSK Position: Q3 2024 in Review

Great Lakes Retirement sold out of GSK (GSK) in Q3 2024, closing a stake of 107 shares — an estimated $13.7K sold.

Great Lakes Retirement first reported a position in GSK in Q4 2022 and held it in 7 quarters. The position peaked at $1.09M in Q1 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Great Lakes Retirement reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Great Lakes Retirement sold 107 GSK shares in Q3 2024, an estimated $13.7K.
  • Great Lakes Retirement first reported a position in GSK in Q4 2022 and held it in 7 quarters.
  • Great Lakes Retirement's GSK position peaked at $1.09M in Q1 2024.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Great Lakes Retirement's 13F filing for Q3 2024, filed 22 Oct 2024.